Cellculture and transient protein expression are part of the expertise Magellan Biologics & Consulting offers to the scientific research community, therefore contributing to the progress of science biology and medicine for the benefit of patients.
We continuously develop our processes and products to propose the most advanced solutions in terms of yield of recombinant proteins, reproducibility and efficiency.
A Historic Milestone: Magellan Biologics & Consulting Enters a New Era with ARCHIMED
Magellan Biologics and its sister company ExcellGene have entered a new strategic partnership with ARCHIMED, a global med-tech investment firm Press Release ARCHIMED acquires cell
25 September 2025
